Tau Therapeutics

About:

Tau Therapeutics engages in the R&D, repositioning and commercialization of calcium T-channel therapies for oncology and other diseases.

Website: http://www.tautherapeutics.com

Description:

Tau Therapeutics LLC, a development stage biopharmaceutical company, focuses on the research, development, repositioning, and commercialization of calcium T-channel therapy agents as cytostatic anti-cancer drugs. It offers calcium T-channel blockers for oncology and other diseases. The company was founded in 2003 and is based in Charlottesville, Virginia.

Total Funding Amount:

$12.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Charlottesville, Virginia, United States

Founded Date:

2003-01-01

Founders:

Andrew J. Krouse, Lloyd Gray, Timothy L. Macdonald

Number of Employees:

1-10

Last Funding Date:

2014-06-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai